4Coull A J, Rothwell P M ; Underestimation of the early risk of recurrent stroke:evidence of the need for a standard definition[ J] . Stroke,2004.
5Sacco R L. Secondary prevention of ischemic stroke:a 1998US per- spective [ J ]. Cerebrovasc Dis, 1999,24 ( 3 ) :37 - 44.
6吴西.阿司匹林抵抗可伴氯吡格雷抵抗.中国医学论坛报,2006,.
7Grotemeyer K H, Scharafinski H W, Husstedt I W. Two year follow - up of aspirin responder and aspirin non responder. A pilot - study in- cluding 180 post- stroke patients [ J]. Thromb Res, 1993,71 (5) : 397 - 403.
8Heglason C M, Bolin K M, Hoff J A. Development of asprin resistance in persons with previous ischemic strock [ J ]. Strock, 1994,25 (12) : 2331 - 2336.
9Papas J N, Westengard J C, Bull B S. Population Variabilily in the effect of aspirin on platelet function. Lmplications for clinical trials and therapy [ J ]. Arch Pathol Lub Med, 1994 : 118 (8) : 801 - 804.
10Gum P A, Kottke - Marchant K, Poqqio E D, et al. Profile and pre- vadence of aspirin resistance in palients with lardivascular disease [J]. Am J Cardio,2001,88(3) :230 -235.
